UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.891-891

2016

Volltextzugriff (PDF)

A Retrospective, Single Institution Study Comparing 5-Fluorouracil, Hydroxyurea, and Twice-Daily Radiation Therapy (FHX) to High-Dose Cisplatin + Radiation Therapy (CRT) in Advanced T Stage Head-and-Neck Squamous Cell Carcinoma (ATSHNSCC)

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.481-481

2014

Volltextzugriff (PDF)

A Retrospective, Single Institution Study Comparing 5-Fluorouracil, Hydroxyurea, and Twice-Daily Radiation Therapy (FHX) to High-Dose Cisplatin + Radiation Therapy (CRT) in Advanced T Stage Head-and-Neck Squamous Cell Carcinoma (ATSHNSCC): Definitive Management of Head-and-Neck Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.481-481

2014

Volltextzugriff (PDF)

Multiple Myeloma :Trends in Consulting Fees and Drug Utilization

Blood, 2019-11, Vol.134 (Supplement_1), p.5823-5823

2019

Volltextzugriff (PDF)

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2019-06, Vol.54 (6), p.839-848

2019

Volltextzugriff (PDF)

Herpes zoster in chronic lymphocytic leukemia: Effect of vaccination and treatment

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7527-7527

2021

Volltextzugriff (PDF)

Safe prolonged use of brentuximab vedotin in a patient with Classical Hodgkin Lymphoma on hemodialysis

Current problems in cancer. Case reports, 2023-09, Vol.11, p.100249, Article 100249

2023

Volltextzugriff (PDF)

Maintenance therapy in multiple myeloma

Therapeutic Advances in Hematology, 2017-02, Vol.8 (2), p.71-79

2017

Volltextzugriff (PDF)

Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018

Stroke (1970), 2020-04, Vol.51 (4), p.1339-1343

2020

Volltextzugriff (PDF)

Prevalence of Colorectal Neoplasms in African Americans in the Age Group of 40-44 Years: 2077

The American journal of gastroenterology, 2013-10, Vol.108, p.S631

2013

Volltextzugriff (PDF)

Bleomycin-induced pulmonary toxicity: A retrospective review of incidence and risk factors

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16532-e16532

2018

Volltextzugriff (PDF)

Serum Free Light Chain Concentration (>1000mg/dl) at Diagnosis and at Relapse Predicts for Very Poor Prognosis in Multiple Myeloma

Blood, 2016-12, Vol.128 (22), p.5698-5698

2016

Volltextzugriff (PDF)

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL)

Blood, 2016-12, Vol.128 (22), p.5410-5410

2016

Volltextzugriff (PDF)

Dosimetric evaluation of an indigenously developed 10 MeV industrial electron beam irradiator

Radiation measurements, 2012-08, Vol.47 (8), p.628-633

2012

Volltextzugriff (PDF)

Delay in COVID-19 Presentation in Patients Recently Treated with CD-19 Directed CAR-T Therapy

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S203-S204

2022

Volltextzugriff (PDF)

250 - Delay in COVID-19 Presentation in Patients Recently Treated with CD-19 Directed CAR-T Therapy

Transplantation and cellular therapy, 2022-03, Vol.28 (3), p.S203-S204

2022

Volltextzugriff (PDF)

Induction Therapy with Dasatinib and Prednisone for Patients with Philadelphia Positive ALL

Blood, 2015-12, Vol.126 (23), p.4907-4907

2015

Volltextzugriff (PDF)

The Effect of Chromosome 1q21 Abnormalities on Outcomes of Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients

Transplantation and cellular therapy, 2024-02, Vol.30 (2), p.S394-S394

2024

Volltextzugriff (PDF)

Mo1182 Colorectal Neoplasm Prevalence in African American and Hispanic Patients in Different Age Groups

Gastroenterology (New York, N.Y. 1943), 2013-05, Vol.144 (5), p.S-600-S-600

2013

Volltextzugriff (PDF)

High serum free light chain concentration (>1000mg/dl) at the time of relapse to predict poor prognosis in multiple myeloma

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.8064-8064

2016

Volltextzugriff (PDF)

COVID 19 Infection in Autologous Stem Cell Transplant (ASCT) Recipients: a Single Institution Observational Cohort

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S343-S343

2023

Volltextzugriff (PDF)

454 - COVID 19 Infection in Autologous Stem Cell Transplant (ASCT) Recipients: a Single Institution Observational Cohort

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S343-S343

2023

Volltextzugriff (PDF)

Case series of unique adverse events related to the use of ibrutinib in patients with B-cell malignancies—A single institution experience and a review of literature

Journal of oncology pharmacy practice, 2019-07, Vol.25 (5), p.1265-1270

2019

Volltextzugriff (PDF)

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

Blood, 2017-12, Vol.130, p.5337-5337

2017

Volltextzugriff (PDF)

Hematopoietic Cell Transplant-Composite Risk (HCT-CR) — a Novel Prognostic Model to Predict Transplant Outcomes

Blood, 2018-11, Vol.132 (Supplement 1), p.2141-2141

2018

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(34)
Berichte
(3)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Life Sciences & Biomedicine
(7)
Oncology
(4)
Case Report
(3)
Dosimetry
(3)
Hematology, Oncology And Palliative Medicine
(3)
Brachytherapy
(2)
Dose Verification
(2)
Hematology
(2)
Humans
(2)
Nuclear Science & Technology
(2)
Radiology
(2)
Stem Cell Transplantation
(2)
Technology
(2)
Tg-43 Formalism
(2)
Transplants & Implants
(2)
Treatment Planning
(2)
Accuracy
(1)
Acute Myeloid Leukemia
(1)
Adverse Event
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

No Difference in Outcome Comparing 5-Fluorouracil, Hydroxyurea, and Twice Daily Radiation Therapy (FHX) to High-Dose Cisplatin and Radiation Therapy (CRT) in Advanced T-Stage Head and Neck Squamous Cell Carcinoma (ATSHNSCC): A Retrospective Study

A Retrospective, Single Institution Study Comparing 5-Fluorouracil, Hydroxyurea, and Twice-Daily Radiation Therapy (FHX) to High-Dose Cisplatin + Radiation Therapy (CRT) in Advanced T Stage Head-and-Neck Squamous Cell Carcinoma (ATSHNSCC)

Multiple Myeloma :Trends in Consulting Fees and Drug Utilization

Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndrome

Herpes zoster in chronic lymphocytic leukemia: Effect of vaccination and treatment

Safe prolonged use of brentuximab vedotin in a patient with Classical Hodgkin Lymphoma on hemodialysis

Maintenance therapy in multiple myeloma

Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018

Prevalence of Colorectal Neoplasms in African Americans in the Age Group of 40-44 Years: 2077

Bleomycin-induced pulmonary toxicity: A retrospective review of incidence and risk factors

Serum Free Light Chain Concentration (>1000mg/dl) at Diagnosis and at Relapse Predicts for Very Poor Prognosis in Multiple Myeloma

Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubucin and Rituximab (da-EPOCH-R) Vs Rituxan, Cyclophosphamide, Doxorubucin, Vincristine and Prednisone (R-CHOP) As First Line Treatment for Diffuse Large B-Cell Lymphoma (DLBCL)

Dosimetric evaluation of an indigenously developed 10 MeV industrial electron beam irradiator

Delay in COVID-19 Presentation in Patients Recently Treated with CD-19 Directed CAR-T Therapy

250 - Delay in COVID-19 Presentation in Patients Recently Treated with CD-19 Directed CAR-T Therapy

Induction Therapy with Dasatinib and Prednisone for Patients with Philadelphia Positive ALL

The Effect of Chromosome 1q21 Abnormalities on Outcomes of Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma Patients

Mo1182 Colorectal Neoplasm Prevalence in African American and Hispanic Patients in Different Age Groups

High serum free light chain concentration (>1000mg/dl) at the time of relapse to predict poor prognosis in multiple myeloma

COVID 19 Infection in Autologous Stem Cell Transplant (ASCT) Recipients: a Single Institution Observational Cohort

454 - COVID 19 Infection in Autologous Stem Cell Transplant (ASCT) Recipients: a Single Institution Observational Cohort

Case series of unique adverse events related to the use of ibrutinib in patients with B-cell malignancies—A single institution experience and a review of literature

Chronic Lymphocytic Leukemia with Deletion 13q: Prognostic Predictors and Outcome after Treatment with Fludarabine, Cyclophosphamide and Rituximab (FCR)

Hematopoietic Cell Transplant-Composite Risk (HCT-CR) — a Novel Prognostic Model to Predict Transplant Outcomes

Aktive Filter

Suchergebnisse filtern